Reply to: Comment on "the role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease"
- PMID: 32166804
- DOI: 10.1002/mds.27972
Reply to: Comment on "the role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease"
Comment on
-
The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease.Mov Disord. 2019 Sep;34(9):1243-1251. doi: 10.1002/mds.27779. Epub 2019 Jul 10. Mov Disord. 2019. PMID: 31291491 Review.
-
Comment on "The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease".Mov Disord. 2020 Mar;35(3):521. doi: 10.1002/mds.27977. Mov Disord. 2020. PMID: 32166803 No abstract available.
References
-
- Xu Y, He Q, Wang W. Comment on “The Role of High-Intensity Focused Ultrasound as a Symptomatic Treatment for Parkinson's Disease.” Mov Disord 2020;35(3):521.
-
- Magara A, Buhler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Ther Ultrasound 2014;2:11.
-
- Schlesinger I, Eran A, Sinai A, et al. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease. Parkinsons Dis 2015;2015:219149.
-
- Ito H, Fukutake S, Yamamoto K, Yamaguchi T, Taira T, Kamei T. Magnetic resonance imaging-guided focused ultrasound thalamotomy for Parkinson's disease. Intern Med 2018;57:1027-1031.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
